Active not recruiting

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

I3Y-MC-JPCP - ClinicalTrials.gov - NCT03703466

The main purpose of this study is to examine the side effects that participants with metastatic breast cancer experience when taking abemaciclib with or without food.
How long will I be in the trial?
Your participation in this trial could last up to 3 months, depending on how you and your tumor respond.
Email
Active not recruiting

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

I3Y-MC-JPCP - ClinicalTrials.gov - NCT03703466

The main purpose of this study is to examine the side effects that participants with metastatic breast cancer experience when taking abemaciclib with or without food.
How long will I be in the trial?
Your participation in this trial could last up to 3 months, depending on how you and your tumor respond.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must be diagnosed with breast cancer that has spread

Participants must have stopped all other forms of treatment for their cancer

Participants must be able to swallow tablets/capsules

Participants must be able to use an electronic diary

Participants must NOT

Participants must not be pregnant or breast feeding

Participants must not have HIV or hepatitis A, B, or C

Participants must not have had major surgery in the past 14 days

Participants must not be currently be receiving treatment in another clinical study

Participants must not have taken abemaciclib or a similar drug before this study

Trial Summary

Conditions the trial is for

Metastatic Breast Cancer, Solid Tumor

What the trial is testing?

Abemaciclib

Could I receive a Placebo?

no

Enrollment Goal

60

Trial Dates

November 2018 - February 2021

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must be diagnosed with breast cancer that has spread

Participants must have stopped all other forms of treatment for their cancer

Participants must be able to swallow tablets/capsules

Participants must be able to use an electronic diary

Participants must NOT

Participants must not be pregnant or breast feeding

Participants must not have HIV or hepatitis A, B, or C

Participants must not have had major surgery in the past 14 days

Participants must not be currently be receiving treatment in another clinical study

Participants must not have taken abemaciclib or a similar drug before this study

Trial Summary

Conditions the trial is for

Metastatic Breast Cancer, Solid Tumor

What the trial is testing?

Abemaciclib

Could I receive a Placebo?

no

Enrollment Goal

60

Trial Dates

November 2018 - February 2021

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?